| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
21 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-12-28 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
The purchase of CompuFlo / CathCheck verification system disposables at two additional
premier hospitals
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced the purchase of CompuFlo Epidural and CathCheck Verification System
disposables from two additional leading hospitals, expanding the Company's geographic
footprint. The name of the hospitals cannot be disclosed for confidentiality reasons.
The Board of Directors of the Company believes that these orders from well recognized
hospitals illustrate the continued traction in the market. Both of these hospitals
belong to large healthcare systems. One of these new hospitals represents an expansion
to an additional location within its existing healthcare system, which, in opinion
of the Board of Directors, is important validation of the technology. The Company
has a growing pipeline of healthcare institutions across the country, and remains
committed to its goal of establishing the CompuFlo Epidural instrument as the new
standard of care in epidural anesthesia.
In the opinion of the Board of Directors of the Company, the clinical and safety benefits
of the CompuFlo Epidural and CathCheck Verification System are backed by numerous
published clinical studies demonstrating reductions in epidural punctures and complication
rates, and can contribute to time savings on the part of anesthesiologists.
|
|
|
RB_ASO: The purchase of CompuFlo / CathCheck verification system disposables at two additional
premier hospitals
